A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatment

Journal of Neuro-Oncology

Volumn 87, Issue 1, 2008, Pages 91-95

  Ogawa, Yoshikazu ^a   Tominaga, Teiji ^b  

^a KOHNAN HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atypical; Ki 67; P53; Pituitary; Thyrotroph

Indexed keywords

KI 67 ANTIGEN; LIOTHYRONINE; OCTREOTIDE; PROLACTIN; PROTEIN P53; STEROID; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; GAMMA KNIFE RADIOSURGERY; HEMIANOPIA; HUMAN; HYPERTHYROIDISM; IMMUNOHISTOCHEMISTRY; LIOTHYRONINE BLOOD LEVEL; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OUTCOME ASSESSMENT; SELLA TURCICA TUMOR; THYROTROPIN BLOOD LEVEL; THYROTROPIN SECRETING ADENOMA; THYROXINE BLOOD LEVEL; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOMA; ADULT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; OCTREOTIDE; PITUITARY NEOPLASMS; THYROTROPHS;

EID: 38649113594     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9492-2     Document Type: Article

References (20)

1. Bertholon-Greoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519-527
2. Delellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and genetics of tumors of endocrine organs. International Agency for Research on Cancer, Lyon
3. Kovacs K, Horvath E (eds) (1986) Tumors of the pituitary gland, 2nd series. Armed Forces Institute of Pathology, Washington
4. Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: Diagnosis and management in 43 patients. Eur J Endocrinol 148:433-442
5. Sanno N, Teramoto A, Osamura Y (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54:179-186
6. Lloyd RV, Kovacs K, Young WF Jr, Farrel WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, Horvath E (2004) Pituitary tumours: Introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs. IARC Press, Lyon, pp 10-13
7. Kontogeorgos G (2005) Classification and pathology of pituitary tumors. Endocrine 28:27-35
8. Kontogeorgos G (2006) Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179-188
9. Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol 156:203-216
10. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr (1996) P53 expression in pituitary adenomas and carcinomas: Correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765-771
11. Ikeda H, Ogawa Y, Yoshimoto T (1999) Ultrastructural characteristics of TSH-producing adenomas with special reference to its close similarity to BFA-treated pituitary adenoma cells. Pituitary 1:221-226
12. Ogawa Y, Ikeda H, Yoshimoto T (1996) Ultrastructural changes in cells of human pituitary adenoma treated by Brefeldin A. Jpn J Clin Electron Microsc 29:69-75
13. Ogawa Y, Tominaga T, Ikeda H (2007) Intrasellar small TSH secreting pituitary adenomas, 2 case reports. No Shinkei Geka 35:679-684
14. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476-486
15. Patrick AW, Atkin SL, MacKenzie J, Foy PM, White MC, MacFarlane IA (1994) Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH alpha-subunit and GH. Clin Endocrinol (Oxf) 40:275-278
16. Sanno N, Teramoto A, Osamura Y (2000) Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93:194-200
17. Beck-Peccoz P, Persani L (2002) Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83-88
18. Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849-2853
19. Dhillon KS, Cohan P, Kelly DF, Darwin CH, Iyer KV, Chopra IJ (2004) Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. J Clin Endocrinol Metab 89:708-711
20. Mixson AJ, Friedman TC, David AK (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529-533